Dear readers,
We wish all visitors to our news page a peaceful and healthy New Year and a successful start to the New Year. Stay healthy! We will be back with the latest news from 4 January.
Best regards
Your editorial team of European Biotechnology Magazine
German researchers find reason for remdesivir’s inefficiency
Latest NewsGerman Researchers have unraveled how remdesivir interferes with the viral RNA polymerase and why it does not block SARS-CoV-2 completely.
LSP reports first closing of dementia fund
Latest NewsEuropean life sciences investors LSP has closed a new fund to fight dementia at €50m.
Valneva in talks with EU about 60 million vaccine doses
Latest NewsFrench Valneva SE announced it is in advanced discussions with the European Commission (EC) for the supply of up to 60 million doses of its COVID-19 vaccine, VLA2001.
Immunocore bags US$75m in Series C round
Latest NewsImmuno-oncology specialist Immunocore plc announced the completion of a $75m Series C private financing round.
Clariant new year, new CEO
AppointmentsMuttenz-based Clariant announced the appointment of Conrad Keijzer as new Chief Executive Officer,
EU approves second COVID-19 vaccine
Latest NewsFollowing a recommendation by the European Medicines Agency (EMA), the European Commission has approved a second vaccine against the novel coronavirus SARS-CoV-2.
Angelini Pharma to take over Arvelle Therapeutics
Latest NewsItalian Angelini Pharma and Swiss CNS disease specialist Arvelle Therapeutics have entered into a definitive merger agreement.
COVID-19 test gives results within minutes
Latest NewsUniversity of Birmingham researchers have invented a COVID-19 RNA test that reduces testing time from 30 minutes to under five, and delivers accurate results.
Merry Christmas and a Happy New Year
Latest NewsDear readers,
We wish all visitors to our news page a peaceful and healthy New Year and a successful start to the New Year. Stay healthy! We will be back with the latest news from 4 January.
Best regards
Your editorial team of European Biotechnology Magazine
EMA greenlights BioNtech’s COVID-19 vaccine
Latest NewsFollowing a rapid FDA approval, the European drug authority EMA has recommended to conditionally approve BioNTech’s mRNA vaccine BNT162b2 in the EU.